Conexiant

Outlet metrics

Domain Authority

Ranking

Global

#1114972

United States

#272846

Articles

Conservative Mental Health Study Faces Retraction

3 days ago | conexiant.com | Kerri Miller |s’ Response

A study examining the association between political conservatism and mental health has been retracted by the Scandinavian Journal of Psychology following a postpublication peer review that identified “major errors involving methods, theory, and normatively biased language.”The article, Do Conservatives Really Have an Advantage in Mental Health? An Examination of Measurement Invariance, authored by Edward Dutton and Emil Kirkegaard, analyzed data from 2 Finnish survey samples (N = 848 and 4,978).
Big Tobacco's Medical Research Infiltrates Journals

4 days ago | conexiant.com | Kerri Miller

An investigation by The Investigative Desk and The BMJ has revealed that research funded by the tobacco industry continues to appear in highly cited medical journals, despite efforts by some publications to sever ties with the industry entirely. The findings document hundreds of relationships between major tobacco companies’ pharmaceutical subsidiaries and published medical research.
Does Sleep Duration Shape Oral Microbiomes?

4 days ago | conexiant.com | Kerri Miller

In a cross-sectional study of 1,332 U.S. adolescents and young adults, investigators found that individuals with long sleep durations exhibited significantly higher oral microbiome diversity compared with those with healthy sleep durations, according to research scheduled for presentation at SLEEP 2025. The study analyzed data from the 2011–2012 National Health and Nutrition Examination Survey (NHANES) for participants aged 16 to 26 years (mean age, 20.9 years; 50.4% female).
Phytosterols Shield Against Diabetes, CVD

5 days ago | conexiant.com | Kerri Miller

Higher dietary intake of phytosterols, particularly beta-sitosterol, may be associated with a lower risk of developing type 2 diabetes and cardiovascular disease, according to a 36-year prospective study conducted by researchers at the Harvard T.H. Chan School of Public Health. The analysis included more than 206,000 participants.
Plant Diet Delays Myeloma Precursor Progression

5 days ago | conexiant.com | Kerri Miller

A high-fiber plant-based dietary intervention may have improved dietary quality and gut microbiome composition in patients with precursor plasma cell disorders, potentially offering the first dietary strategy to delay progression from monoclonal gammopathy of undetermined significance and smoldering multiple myeloma to active multiple myeloma, according to results from a pilot clinical trial conducted at Memorial Sloan Kettering Cancer Center.
New COVID Vaccine Approved for High-Risk Groups

6 days ago | conexiant.com | Kathryn Wighton

Moderna’s newly approved mNEXSPIKE vaccine demonstrated a 13.5% higher relative efficacy than Spikevax in adults aged 65 years and older, according to phase 3 trial data. The FDA has approved Moderna’s COVID-19 vaccine mNEXSPIKE (mRNA-1283) for adults aged 65 years and older and patients aged 12 to 64 years with one or more underlying risk factors, as defined by the CDC.
CDC Holds Line on Kids' COVID Shots

1 week ago | conexiant.com | Susan Heavey |Puyaan Singh

The CDC is still recommending COVID-19 vaccines for healthy children, according to its latest published immunization schedule. The schedule, published late on Thursday by the public health agency, comes after Health and Human Services Secretary Robert F. Kennedy Jr. — alongside the heads of the FDA and the National Institutes of Health — earlier this week said the CDC would stop recommending routine COVID vaccines for healthy children and pregnant women.
Major Medical Societies Issue GLP-1 Nutrition Guidelines

1 week ago | conexiant.com | Kerri Miller

Four major medical organizations have released comprehensive nutritional guidance for clinicians prescribing glucagon-like peptide-1 receptor agonists for obesity treatment. These guidelines address growing concerns about medication adherence, side effects, and long-term efficacy.
Extra Boost Before Surgery Shows Promise

1 week ago | conexiant.com | Nancy Lapid

A cancer immunotherapy drug from China’s BeiGene, previously used in inoperable esophageal cancer, may also change how some operable esophagus tumors are treated, according to findings from a phase 2 trial. In the study, patients with newly diagnosed esophageal cancer that had extended beyond its original location received standard preoperative chemoradiation.
FDA Approves First Hydrocortisone Oral Solution

1 week ago | conexiant.com | Kathryn Wighton

Eton Pharmaceuticals announced U.S. Food and Drug Administration approval of Khindivi (hydrocortisone) Oral Solution for replacement therapy in pediatric patients aged 5 years and older with adrenocortical insufficiency. Khindivi is the first U.S. Food and Drug Administration (FDA)-approved oral liquid formulation of hydrocortisone and is available in a 1 mg/mL concentration.